HaemoneticsCorp tweet coincides with Haemonetics stock surging 5.78 percent to 79.21

Traders Union
All News
Companies
Haemonetics surges 5.78% to $79.21 today

Highlights

HAE trades at $79.21 after an 11.34% weekly surge, showing strong bullish momentum across all trend timeframes.
Momentum indicators confirm continued upward strength but signal overbought conditions and a heightened risk of short-term profit-taking.
HAE is expected to consolidate between $78.11 and $80.01 next week, with potential for a breakout toward yearly highs if bullish momentum persists.

Bullish trend confirmed as price extends above key moving averages

HAE is trading at $79.21, significantly above the MA-20 ($63.11), MA-50 ($60.22), and MA-200 ($62.93), confirming strong bullish momentum across short-, medium-, and long-term trends. The Ichimoku Kijun at $63.45 sits well below current levels, providing immediate support.

Sustained buying momentum despite signals of overbought market conditions

Momentum indicators on D1 affirm bullish pressure, with both MACD and ADX signaling ongoing upward strength. However, RSI (77.24), Stoch RSI (100), and CCI (133.91) all highlight heavily overbought conditions, while BBP emphasizes dominant buyer momentum. The Awesome Oscillator also aligns with the prevailing uptrend. In today's session, HAE posts a sharp gain of 5.78%, reflecting robust buying. Over the past week, HAE is trading at $79.21, moving up from a previous weekly close of $71.28—a rise of 11.34%. The price is positioned at the very top of the weekly range, with weekly volatility standing at 16.25%. This marks a notable rally and recovery from recent lows, but with short-term technicals signaling stretched market conditions.

Upside probability elevated as consolidation expected near resistance

For the coming week, the expected price range is $78.11 to $80.01, sitting well above the year’s low ($47.32) but still below the 52-week high ($87.32). The probability of further price increase is high (more than 80%), with a very low chance of a reversal lower. Baseline scenario: HAE holds between immediate support and resistance, stabilizing in a sideways band as recent gains consolidate. Bullish scenario: a breakout above $80.01 could open room for tests closer to yearly highs if momentum remains strong. Bearish scenario: a drop below $78.11 may trigger short-term profit-taking, but the broader trend and support levels suggest any decline would likely be limited.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Earlier, analysts noted that Haemonetics maintained a broadly constructive technical setup with a bias toward further consolidation, though upside momentum appeared limited. As current dynamics continue to unfold, market participants should focus on whether the stock sustains its position above key support areas, as this will be pivotal for near-term direction.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.